Waters Corporation Debt/Equity

Debt/Equity of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including Debt/Equity growth rates and interactive chart. The debt-to-equity (D/E) ratio is calculated by dividing a company's total interest-bearing liabilities by its shareholder equity. These numbers are available on the balance sheet of a company's financial statements. The ratio is used to evaluate a company's financial leverage. The debt/equity ratio can be compared to a company's historical average or to peers. A ratio above 1 indicates the company has more debt than equity and a ratio above 3 is considered high. Below 0.5 means the company has little debt and significant capacity to expand it.

Highlights and Quick Summary

  • Debt/Equity for the quarter ending December 30, 2020 was 5.2 (a -115.2% decrease compared to previous quarter)
  • Year-over-year quarterly Debt/Equity decreased by -193.74%
  • Annual Debt/Equity for 2020 was 5.2 (a -169.91% decrease from previous year)
  • Annual Debt/Equity for 2019 was -7.43 (a -1114.8% decrease from previous year)
  • Annual Debt/Equity for 2018 was 0.73 (a -13.76% decrease from previous year)
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Debt/Equity of Waters Corporation

Most recent Debt/Equityof WAT including historical data for past 10 years.

Interactive Chart of Debt/Equity of Waters Corporation

Waters Corporation Debt/Equity for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 5.2 -34.18 -8.2 -5.54 5.2
2019 -7.43 11.08 1.93 1.11 -7.43
2018 0.73 0.61 0.58 0.59 0.73
2017 0.85 0.66 0.67 0.69 0.85
2016 0.74 0.73 0.76 0.76 0.74
2015 0.73 0.74 0.72 0.7 0.73
2014 0.65 0.65 0.63 0.6 0.65
2013 0.67 0.72 0.75 0.75 0.67
2012 0.71 0.53 0.55 0.54 0.71
2011 0.57 0.6 0.57 0.35 0.57
2010 0.65 0.76 0.86 0.65

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.